Wade D P, Knight B L, Soutar A K
Eur J Biochem. 1986 Sep 1;159(2):333-40. doi: 10.1111/j.1432-1033.1986.tb09872.x.
In this paper, human low-density lipoprotein (LDL), rat chylomicron remnants and very-low-density lipoproteins of beta-mobility from cholesterol-fed rabbits (beta VLDL) have been shown to bind strongly to a protein present in solubilised liver membranes of rats, rabbits and dogs by ligand blotting with biotin-modified lipoproteins. This binding protein was identified as the LDL-receptor on several criteria. First, binding of the lipoproteins to the receptor was saturable and Ca2+-dependent; secondly, the apparent relative molecular mass of the binding protein (ranging from 128,000 in the rabbit, 145,000 in the rat to 147,000 in the dog) was similar to that of the purified bovine LDL receptor. Finally, binding activity was greatly increased in the livers of rats treated with oestrogen in pharmacological doses and absent from the liver of Watanabe heritable hyperlipidaemic (WHHL) rabbits that have a genetic defect in the LDL receptor. Some binding was also observed to a high-molecular-mass protein present in solubilised liver membranes of rats and rabbits, which, in rabbits at least, shared antigenic determinants with rabbit apoB and was not likely to be related to the LDL receptor as it was present in equal amounts in normal and WHHL rabbits. No evidence was obtained for a specific chylomicron remnant binding protein, distinct from the LDL receptor, whose activity could be detected in solubilised liver membranes by ligand blotting although a variety of solubilisation and fractionation conditions were employed.
在本文中,通过用生物素修饰的脂蛋白进行配体印迹法已表明,人低密度脂蛋白(LDL)、大鼠乳糜微粒残粒以及来自胆固醇喂养兔的β-迁移率极低密度脂蛋白(β-VLDL)能与大鼠、兔和犬的溶解肝细胞膜中存在的一种蛋白质强烈结合。基于多项标准,这种结合蛋白被鉴定为LDL受体。首先,脂蛋白与受体的结合是可饱和的且依赖Ca2+;其次,结合蛋白的表观相对分子质量(兔为128,000,大鼠为145,000,犬为147,000)与纯化的牛LDL受体相似。最后,在用药理剂量雌激素处理的大鼠肝脏中,结合活性大幅增加,而在LDL受体存在基因缺陷的渡边遗传性高脂血症(WHHL)兔的肝脏中则不存在这种活性。在大鼠和兔的溶解肝细胞膜中还观察到与一种高分子质量蛋白的一些结合,至少在兔中,该蛋白与兔载脂蛋白B具有共同的抗原决定簇,并且由于其在正常兔和WHHL兔中含量相等,所以不太可能与LDL受体相关。尽管采用了多种溶解和分级分离条件,但未获得与LDL受体不同的特异性乳糜微粒残粒结合蛋白的证据,其活性可通过配体印迹法在溶解肝细胞膜中检测到。